Jazz Pharmaceuticals · 2 months ago
Sr. Medical Science Liaison- EPILEPSY, Texas (Remote)
Jazz Pharmaceuticals is a global biopharma company dedicated to developing life-changing medicines for patients with serious diseases. The Senior Medical Science Liaison (MSL) will engage with key opinion leaders in the Epilepsy therapeutic area, providing scientific support and enhancing professional relationships within the medical community.
BiotechnologyHealth CarePharmaceutical
Responsibilities
Identify and develop peer-to-peer relationships with key opinion leaders (KOLs) and healthcare providers within the Epilepsy therapeutic area
Develop and execute territory plans in alignment with US Medical Affairs plans
Identify and communicate key clinical and research issues and insights from KOLs to appropriate departments
Participate in medical education for healthcare professionals (HCPs) through on-site presentations at healthcare institutions, investigator meetings, national conferences, advisory boards, or regional meetings
Provide scientific support for additional activities such as medical congress staffing, advisory boards, and sales training initiatives
Maintains an up to date and high-level knowledge of the therapy area, Jazz products, new and emerging areas of research, therapeutic issues and trends, and competitive landscape
Establishes reputation as a trustworthy and knowledgeable source of scientific and medical information for the healthcare community
Supports development of Jazz Pharmaceuticals positioning as the scientific authority in Epilepsy. Attends appropriate scientific congresses to stay abreast of developments and to support Regional, National and local KOL activities and Jazz interests
Acquires a broad understanding of local and national protocols and standards of clinical practice and trends in disease management in the US
Provide clinical presentations and information in response to unsolicited questions (as appropriate) in academic, community, and healthcare provider settings in both group and one-on-one situations
Communicates emerging data and the clinical experience with our products through scientific exchange and peer-to-peer interactions discussing benefits and risks in an objective manner
Provide scientific support for additional activities such as medical congress staffing, advisory boards, and sales training initiatives
Act as primary liaison to investigators interested in performing investigator-initiated trials (IIT)
Monitor investigator-initiated research, review study design, and oversee milestone requirements to ensure progression of investigator- or company-sponsored clinical research
Collaborate with medical affairs and clinical organization to support patient enrollment in our company's sponsored clinical trials with site recommendations
Serve (as needed) as internal scientific advisor in the evaluation of new products and technologies under consideration for portfolio enhancement/expansion
Contributes to the development of the US Medical Plan and provides input into local strategies and tactics
Where needed, manages relevant budget to enable execution of Medical Plan tactics as part of the wider Medical Affairs team
Works in a collaborative manner with cross-functional colleagues to ensure a Key Account Management approach
Interacts with HCPs as a scientific resource to support activities aligned with the Medical Plan including advisory boards, speaker development and clinical trials
Consistently acts to enhance Jazz Pharmaceuticals’ image as an advocate of medical advancement by using knowledge of product, disease state and pipeline products to engage healthcare providers in meaningful scientific exchange of information
Document and forward reports of adverse events and product complaints according to Jazz’s policy to ensure safe and effective use of Jazz Pharmaceuticals' products
Adheres to the relevant national and local Codes of Practice
Behaves ethically and with integrity at all times
Acts as an ambassador for Jazz Pharmaceuticals following company mission and values
Keeps own written development plan and implements
Prepares timely reporting according to the company needs
Qualification
Required
Ability to research and critically analyze and communicate complex scientific and medical information and data
Ability and willingness to travel at least 60% of work days, Driving required
Clear and concise communication and presentation skills
Excellent planning and organization skills, with high-level attention to detail and accuracy
Strong strategic mindset
Highly self-motivated and ability to work autonomously
Ability to learn quickly, be flexible and results-focused in a rapidly changing environment
Excellent negotiation skills
Demonstrated skills in inter-personal relationship building, networking, collaboration and teamwork
Strong capabilities working with digital platforms and tools are required
Excellent command of spoken English
MS/Advanced Practice Degree in scientific and/or medical discipline with a minimum of 5 years experience in Epilepsy -or- MD, PharmD, or PhD is required
MSL experience in Neurology is required and experience in Epilepsy is strongly preferred
Minimum 3 years experience as a Medical Science Liaison with a strong track record of success
This is a field position and applicants must be willing to travel 60-80% time
Valid driver's license and live within 60 miles of a major airport
Preferred
Knowledge of geography, healthcare environment and external experts in academia and medical community
Demonstrated ability to develop trust and relationships with opinion leaders in disease states of interest
Understanding of regulatory requirements for field-based personnel
Benefits
Medical, dental and vision insurance
401k retirement savings plan
Flexible paid vacation
Company
Jazz Pharmaceuticals
Jazz Pharmaceuticals is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments.
Funding
Current Stage
Public CompanyTotal Funding
$2.81BKey Investors
Longitude CapitalKohlberg Kravis Roberts
2024-09-03Post Ipo Debt· $850M
2021-04-22Post Ipo Debt· $1.5B
2009-12-07Post Ipo Debt· $120M
Leadership Team
Recent News
2026-01-22
2026-01-16
Company data provided by crunchbase